HK1084445A1 - Methods to predict cholesterol elevations during immunosuppressant therapy - Google Patents
Methods to predict cholesterol elevations during immunosuppressant therapyInfo
- Publication number
- HK1084445A1 HK1084445A1 HK06104588.4A HK06104588A HK1084445A1 HK 1084445 A1 HK1084445 A1 HK 1084445A1 HK 06104588 A HK06104588 A HK 06104588A HK 1084445 A1 HK1084445 A1 HK 1084445A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- predict
- immunosuppressant therapy
- elevations during
- cholesterol
- Prior art date
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 235000012000 cholesterol Nutrition 0.000 title 1
- 229960003444 immunosuppressant agent Drugs 0.000 title 1
- 230000001861 immunosuppressant effect Effects 0.000 title 1
- 239000003018 immunosuppressive agent Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41512302P | 2002-09-30 | 2002-09-30 | |
| PCT/EP2003/010798 WO2004029618A2 (fr) | 2002-09-30 | 2003-09-29 | Procedes pour prevoir des elevations de cholesterol durant une therapie immunosuppressive |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1084445A1 true HK1084445A1 (en) | 2006-07-28 |
Family
ID=32043422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK06104588.4A HK1084445A1 (en) | 2002-09-30 | 2006-04-18 | Methods to predict cholesterol elevations during immunosuppressant therapy |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7732134B2 (fr) |
| EP (1) | EP1549770B1 (fr) |
| JP (1) | JP4575775B2 (fr) |
| CN (1) | CN100453650C (fr) |
| AT (1) | ATE389034T1 (fr) |
| AU (1) | AU2003287955B2 (fr) |
| BR (1) | BR0314552A (fr) |
| CA (1) | CA2500979A1 (fr) |
| DE (1) | DE60319719T2 (fr) |
| ES (1) | ES2302959T3 (fr) |
| HK (1) | HK1084445A1 (fr) |
| IL (1) | IL167639A (fr) |
| PT (1) | PT1549770E (fr) |
| WO (1) | WO2004029618A2 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007015083A (es) * | 2005-05-31 | 2008-01-17 | Novartis Ag | Combinacion de inhibidores de hmg-coa-reductasa e inhibidores de mtor. |
| GB2488289A (en) | 2009-11-06 | 2012-08-22 | Univ Leland Stanford Junior | Non-invasive diagnosis of graft rejection in organ transplant patients |
| KR101924162B1 (ko) * | 2010-03-15 | 2018-11-30 | 버지니아 커먼웰스 유니버시티 | 기도의 염증 및 이상성 점액섬모 전달의 치료법으로서의 에어로졸화 댑손 |
| US20130203769A1 (en) * | 2012-02-08 | 2013-08-08 | University Of Cincinnati | Targeting Metabolic Adaptive Responses to Chemotherapy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686246A (en) | 1995-08-03 | 1997-11-11 | Kornman; Kenneth S. | Detecting genetic predisposition to periodontal disease |
| US5698399A (en) * | 1996-04-05 | 1997-12-16 | Duff; Gordon W. | Detecting genetic predisposition for osteoporosis |
| US6524795B1 (en) | 1997-03-10 | 2003-02-25 | Interleukin Genetics, Inc. | Diagnostics for cardiovascular disorders |
| US6210877B1 (en) * | 1997-03-10 | 2001-04-03 | Interleukin Genetics, Inc. | Prediction of coronary artery disease |
| GB9711040D0 (en) * | 1997-05-29 | 1997-07-23 | Duff Gordon W | Prediction of inflammatory disease |
| CA2467717A1 (fr) * | 2001-11-19 | 2003-05-30 | Interleukin Genetics, Inc. | Polymorphismes fonctionnels du site de l'interleukine-1 affectant la transcription et la susceptibilite aux affections inflammatoires et infectieuses |
-
2003
- 2003-09-29 CN CNB038233428A patent/CN100453650C/zh not_active Expired - Fee Related
- 2003-09-29 US US10/529,613 patent/US7732134B2/en not_active Expired - Fee Related
- 2003-09-29 ES ES03779798T patent/ES2302959T3/es not_active Expired - Lifetime
- 2003-09-29 AU AU2003287955A patent/AU2003287955B2/en not_active Ceased
- 2003-09-29 WO PCT/EP2003/010798 patent/WO2004029618A2/fr active Application Filing
- 2003-09-29 AT AT03779798T patent/ATE389034T1/de active
- 2003-09-29 CA CA002500979A patent/CA2500979A1/fr not_active Abandoned
- 2003-09-29 EP EP03779798A patent/EP1549770B1/fr not_active Expired - Lifetime
- 2003-09-29 PT PT03779798T patent/PT1549770E/pt unknown
- 2003-09-29 JP JP2004539048A patent/JP4575775B2/ja not_active Expired - Fee Related
- 2003-09-29 DE DE60319719T patent/DE60319719T2/de not_active Expired - Lifetime
- 2003-09-29 BR BR0314552-2A patent/BR0314552A/pt not_active IP Right Cessation
-
2005
- 2005-03-24 IL IL167639A patent/IL167639A/en not_active IP Right Cessation
-
2006
- 2006-04-18 HK HK06104588.4A patent/HK1084445A1/xx not_active IP Right Cessation
-
2010
- 2010-02-15 US US12/705,754 patent/US20100184798A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003287955A1 (en) | 2004-04-19 |
| CN100453650C (zh) | 2009-01-21 |
| JP2006500930A (ja) | 2006-01-12 |
| DE60319719D1 (de) | 2008-04-24 |
| PT1549770E (pt) | 2008-06-24 |
| AU2003287955B2 (en) | 2007-06-21 |
| CN1685062A (zh) | 2005-10-19 |
| US20100184798A1 (en) | 2010-07-22 |
| US7732134B2 (en) | 2010-06-08 |
| US20060246439A1 (en) | 2006-11-02 |
| AU2003287955B9 (en) | 2004-04-19 |
| WO2004029618A3 (fr) | 2004-06-17 |
| EP1549770B1 (fr) | 2008-03-12 |
| DE60319719T2 (de) | 2009-03-12 |
| IL167639A (en) | 2011-10-31 |
| BR0314552A (pt) | 2005-08-09 |
| ATE389034T1 (de) | 2008-03-15 |
| ES2302959T3 (es) | 2008-08-01 |
| WO2004029618A2 (fr) | 2004-04-08 |
| EP1549770A2 (fr) | 2005-07-06 |
| CA2500979A1 (fr) | 2004-04-08 |
| JP4575775B2 (ja) | 2010-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20070052L (no) | Fremgangsmate for behandling av multippel sklerose | |
| MY151032A (en) | Treatment of tnf? related disorders | |
| TNSN05300A1 (en) | Treatment with anti-vegf antibodies | |
| DE602004029159D1 (fr) | ||
| WO2006076651A3 (fr) | Procede de traitement | |
| MX349188B (es) | Sns - 595 y metodos para utilizar el mismo. | |
| TW200635608A (en) | Aβ antibodies for use in improving cognition | |
| TW200635607A (en) | Humanized Aβ antibodies for use in improving cognition | |
| WO2004092405A3 (fr) | Gene d'hemochromatose juvenile (hfe2a), produits d'expression et leurs utilisations | |
| WO2003090695A3 (fr) | Traitement d'un deficit en alpha-galactosidase a | |
| HK1064950A1 (en) | Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) | |
| MXPA04006572A (es) | Terapia de combinacion antivirica. | |
| WO2003026643A3 (fr) | Methodes et combinaisons therapeutiques utiles pour le traitement du xanthome effectue avec des inhibiteurs d'absorption du sterol | |
| WO2007081790A3 (fr) | Procedes de diagnostic et de traitement du cancer de la prostate | |
| HK1084445A1 (en) | Methods to predict cholesterol elevations during immunosuppressant therapy | |
| HK1099525A1 (en) | Methods of treating atherosclerosis | |
| TW200508233A (en) | Chk-1 inhibitors | |
| WO2004004653A3 (fr) | Methodes de traitement de la psychose associee a une therapie aux interferon $g(a) | |
| WO2006004774A3 (fr) | Analogues de laulimalide en tant qu'agents therapeutiques | |
| MXPA04010927A (es) | Metodos y composiciones para el tratamiento de enfermedades y trastornos inflamatorios/autoinmunes producidos por linfocitos t en sujetos que padecen una deficiencia en la regulacion de glucocorticoides. | |
| WO2005094282A3 (fr) | Therapie combinatoire comprenant la cloretazine™ | |
| WO2003079748A3 (fr) | Renforcement de therapies cancereuses par inhibition de znf217 | |
| WO2003063784A3 (fr) | Molecules modulant l'activite de g$g(a)q et methodes de traitement de l'incontinence urinaire | |
| AU2003229876A1 (en) | Tumour associated antigens | |
| WO2004006950A3 (fr) | Utilisation de cd152 pour le traitement de maladies auto-immunes et d'inflammations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20130929 |